Serrano et al., 1998 - Google Patents
Familial Mediterranean fever and acute myocardial infarction secondary to coronary vasculitisSerrano et al., 1998
View PDF- Document ID
- 2175598252033920991
- Author
- Serrano R
- Martínez M
- Andrés A
- Morales J
- Samartin R
- Publication year
- Publication venue
- Histopathology
External Links
Snippet
Aims We report a case study to elucidate the pathogenesis of polyarteritis nodosa (PAN) type vasculitis, a rare complication of familial mediterranean fever (FMF). Methods and results A woman with amyloidosis complicating FMF underwent a cadaveric renal …
- 206010016207 Familial mediterranean fever 0 title abstract description 38
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Starzl et al. | Immunosuppression after experimental and clinical homotransplantation of the liver | |
Efthimiou et al. | Pulmonary Disease in Behç's Syndrome | |
Keane et al. | Radiation-induced renal disease: A clinicopathologic study | |
Trojanowski et al. | Hepatic and splenic infarctions: complications of therapeutic transcatheter embolization | |
Morris et al. | RENAL ARTERY STENOSIS IN RENAL TRANSPLANTATION1 | |
CN105899213B (en) | Method for Oxidizing Cholesterol Sulfate (OCS) | |
Bennett et al. | Posttransplant hypertension: Studies of cortical blood flow and the renal pressor system | |
Margules et al. | Surgical correction of renovascular hypertension following renal allotransplantation | |
Sevitt et al. | Acute oliguric renal failure due to accelerated (malignant) hypertension | |
Serrano et al. | Familial Mediterranean fever and acute myocardial infarction secondary to coronary vasculitis | |
Iwatsuki et al. | Current status of hepatic transplantation | |
Okiye et al. | Acute dissecting aneurysm of the aorta after renal transplantation | |
Breedveld et al. | Rapidly progressive glomerulonephritis with glomerular crescent formation in rheumatoid arthritis | |
Moncrieff et al. | Haemolytic-uraemic syndrome treated with heparin | |
Koten et al. | Two cases of primary oxalosis | |
Fergus et al. | Kidney function after renal arterial embolism | |
Kirschfink | C1-inhibitor and transplantation | |
IRIE et al. | Fatal hepatic necrosis after shock | |
Burch et al. | Lower nephron syndrome | |
FIGUEROA et al. | Renal homotransplantation in man: report of six consecutive cases | |
Glassock et al. | Hypertension in a renal transplant recipient | |
Sullivan et al. | Embolization of a solitary kidney: Successful embolectomy after nine days | |
CA2625888C (en) | Method of treating acute renal failure with thrombomodulin variant | |
Richmond et al. | Coronary bypass grafting in the early stages of acute myocardial infarction | |
JPH07196650A (en) | Argatroban pharmaceutical preparation having action suppressing proliferation of smooth muscle cell |